Notice Information
Notice Title
NHS National Pharmaceuticals -- Fulvestrant, Darunavir and Imatinib
Notice Description
Project title: invitation to offer for NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021.
Lot Information
Lot 1
Project title: invitation to offer for NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.
Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-029839
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/004316-2021
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1
Notice Dates
- Publication Date
- 4 Mar 20214 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 15 Jan 20215 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
- Contact Name
- Not specified
- Contact Email
- gemma.tomlinson1@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- RUNCORN
- Postcode
- WA7 2ES
- Post Town
- Warrington
- Country
- England
-
- Major Region (ITL 1)
- TLD North West (England)
- Basic Region (ITL 2)
- TLD7 Merseyside
- Small Region (ITL 3)
- TLD71 East Merseyside
- Delivery Location
- Not specified
-
- Local Authority
- Halton
- Electoral Ward
- Halton Lea
- Westminster Constituency
- Runcorn and Helsby
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-029839-2021-03-04T10:27:46Z",
"date": "2021-03-04T10:27:46Z",
"ocid": "ocds-h6vhtk-029839",
"initiationType": "tender",
"tender": {
"id": "CM/PHG/20/5627",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NHS National Pharmaceuticals -- Fulvestrant, Darunavir and Imatinib",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods",
"description": "Project title: invitation to offer for NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021.",
"lots": [
{
"id": "1",
"description": "Project title: invitation to offer for NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"hasOptions": true,
"options": {
"description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement."
},
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"procedure": {
"isAccelerated": true,
"acceleratedRationale": "This requirement to call for competition came about due to the availability of competitive supply in circumstances relating to intellectual property rights that could not have been foreseen and/or acted upon by the authority using regular tender timescales."
},
"techniques": {
"hasFrameworkAgreement": true
},
"coveredBy": [
"GPA"
]
},
"awards": [
{
"id": "004316-2021-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7486",
"name": "Accord-UK Ltd"
}
]
},
{
"id": "004316-2021-2",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7487",
"name": "Thornton and Ross Ltd"
}
]
},
{
"id": "004316-2021-3",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7488",
"name": "Zentiva Pharma UK Ltd"
}
]
},
{
"id": "004316-2021-4",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7489",
"name": "AstraZeneca"
}
]
},
{
"id": "004316-2021-5",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7490",
"name": "Cipla (EU) Ltd"
}
]
},
{
"id": "004316-2021-6",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7491",
"name": "Dr.Reddy's Laboratories (UK) Limited"
}
]
},
{
"id": "004316-2021-7",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7492",
"name": "Janssen-Cilag Ltd"
}
]
},
{
"id": "004316-2021-8",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7493",
"name": "Sandoz Ltd"
}
]
},
{
"id": "004316-2021-9",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7494",
"name": "Teva UK Limited"
}
]
},
{
"id": "004316-2021-10",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-7495",
"name": "Novartis Pharmaceuticals UK Ltd"
}
]
}
],
"parties": [
{
"id": "GB-FTS-2505",
"name": "The NHS Commissioning Board (operating under the name of NHS England)",
"identifier": {
"legalName": "The NHS Commissioning Board (operating under the name of NHS England)"
},
"address": {
"streetAddress": "2nd Floor, Rutland House",
"locality": "Runcorn",
"region": "UK",
"postalCode": "WA7 2ES",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "gemma.tomlinson1@nhs.net"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-7486",
"name": "Accord-UK Ltd",
"identifier": {
"legalName": "Accord-UK Ltd"
},
"address": {
"locality": "Barnstaple",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7487",
"name": "Thornton and Ross Ltd",
"identifier": {
"legalName": "Thornton and Ross Ltd"
},
"address": {
"locality": "Huddersfield",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7488",
"name": "Zentiva Pharma UK Ltd",
"identifier": {
"legalName": "Zentiva Pharma UK Ltd"
},
"address": {
"locality": "London",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7489",
"name": "AstraZeneca",
"identifier": {
"legalName": "AstraZeneca"
},
"address": {
"locality": "Luton",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7490",
"name": "Cipla (EU) Ltd",
"identifier": {
"legalName": "Cipla (EU) Ltd"
},
"address": {
"locality": "Addlestone",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-7491",
"name": "Dr.Reddy's Laboratories (UK) Limited",
"identifier": {
"legalName": "Dr.Reddy's Laboratories (UK) Limited"
},
"address": {
"locality": "Beverley",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-7492",
"name": "Janssen-Cilag Ltd",
"identifier": {
"legalName": "Janssen-Cilag Ltd"
},
"address": {
"locality": "High Wycombe",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7493",
"name": "Sandoz Ltd",
"identifier": {
"legalName": "Sandoz Ltd"
},
"address": {
"locality": "Camberley",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
},
{
"id": "GB-FTS-7494",
"name": "Teva UK Limited",
"identifier": {
"legalName": "Teva UK Limited"
},
"address": {
"locality": "Castleford",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-7495",
"name": "Novartis Pharmaceuticals UK Ltd",
"identifier": {
"legalName": "Novartis Pharmaceuticals UK Ltd"
},
"address": {
"locality": "London",
"region": "UK",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-497",
"name": "The High Court",
"identifier": {
"legalName": "The High Court"
},
"address": {
"streetAddress": "Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "generaloffice@administrativecourtoffice.justice.gov.uk"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.gov.uk/courts-tribunals"
}
}
],
"buyer": {
"id": "GB-FTS-2505",
"name": "The NHS Commissioning Board (operating under the name of NHS England)"
},
"contracts": [
{
"id": "004316-2021-1",
"awardID": "004316-2021-1",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
},
{
"id": "004316-2021-2",
"awardID": "004316-2021-2",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
},
{
"id": "004316-2021-3",
"awardID": "004316-2021-3",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
},
{
"id": "004316-2021-4",
"awardID": "004316-2021-4",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
},
{
"id": "004316-2021-5",
"awardID": "004316-2021-5",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
},
{
"id": "004316-2021-6",
"awardID": "004316-2021-6",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
},
{
"id": "004316-2021-7",
"awardID": "004316-2021-7",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
},
{
"id": "004316-2021-8",
"awardID": "004316-2021-8",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
},
{
"id": "004316-2021-9",
"awardID": "004316-2021-9",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
},
{
"id": "004316-2021-10",
"awardID": "004316-2021-10",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 16
},
{
"id": "4",
"measure": "bids",
"relatedLot": "1",
"value": 16
},
{
"id": "7",
"measure": "bids",
"relatedLot": "1",
"value": 16
},
{
"id": "10",
"measure": "bids",
"relatedLot": "1",
"value": 16
},
{
"id": "13",
"measure": "bids",
"relatedLot": "1",
"value": 16
},
{
"id": "16",
"measure": "bids",
"relatedLot": "1",
"value": 16
},
{
"id": "19",
"measure": "bids",
"relatedLot": "1",
"value": 16
},
{
"id": "22",
"measure": "bids",
"relatedLot": "1",
"value": 16
},
{
"id": "25",
"measure": "bids",
"relatedLot": "1",
"value": 16
},
{
"id": "28",
"measure": "bids",
"relatedLot": "1",
"value": 16
},
{
"id": "2",
"measure": "smeBids",
"relatedLot": "1",
"value": 8
},
{
"id": "5",
"measure": "smeBids",
"relatedLot": "1",
"value": 8
},
{
"id": "8",
"measure": "smeBids",
"relatedLot": "1",
"value": 8
},
{
"id": "11",
"measure": "smeBids",
"relatedLot": "1",
"value": 8
},
{
"id": "14",
"measure": "smeBids",
"relatedLot": "1",
"value": 8
},
{
"id": "17",
"measure": "smeBids",
"relatedLot": "1",
"value": 8
},
{
"id": "20",
"measure": "smeBids",
"relatedLot": "1",
"value": 8
},
{
"id": "23",
"measure": "smeBids",
"relatedLot": "1",
"value": 8
},
{
"id": "26",
"measure": "smeBids",
"relatedLot": "1",
"value": 8
},
{
"id": "29",
"measure": "smeBids",
"relatedLot": "1",
"value": 8
},
{
"id": "3",
"measure": "electronicBids",
"relatedLot": "1",
"value": 16
},
{
"id": "6",
"measure": "electronicBids",
"relatedLot": "1",
"value": 16
},
{
"id": "9",
"measure": "electronicBids",
"relatedLot": "1",
"value": 16
},
{
"id": "12",
"measure": "electronicBids",
"relatedLot": "1",
"value": 16
},
{
"id": "15",
"measure": "electronicBids",
"relatedLot": "1",
"value": 16
},
{
"id": "18",
"measure": "electronicBids",
"relatedLot": "1",
"value": 16
},
{
"id": "21",
"measure": "electronicBids",
"relatedLot": "1",
"value": 16
},
{
"id": "24",
"measure": "electronicBids",
"relatedLot": "1",
"value": 16
},
{
"id": "27",
"measure": "electronicBids",
"relatedLot": "1",
"value": 16
},
{
"id": "30",
"measure": "electronicBids",
"relatedLot": "1",
"value": 16
}
]
},
"links": [
{
"rel": "prev",
"href": "https://ted.europa.eu/udl?uri=TED:NOTICE:562997-2020:TEXT:EN:HTML"
}
],
"language": "en"
}